why is semaglutide being banned Did the FDA Ban Compounded and Tirzepatide? Compounded Semaglutide Manufacturing Ban

Beyond its primary indication for diabetes management, emerging evidence suggests that GLP-1 receptor agonists may offer additional metabolic benefits

With its ability to reduce appetite, enhance metabolic health, and foster mental well-being, semaglutide offers a multifaceted approach to weight management

Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Compounded Semaglutide (GLP-1) Injections A once-weekly GLP-1 injection designed to help reduce appetite, improve metabolic health, and support sustainable weight loss under licensed medical supervision

The exposure of semaglutide decreases with an increase in body weight